Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

AstraZeneca axes Moderna-partnered, phase 2 heart disease drug plus a Wee inhibitor
Fierce Biotech
Fri, 07/29/22 - 10:12 am
Tags:
AstraZeneca, Moderna Therapeutics, heart disease, MRNA, Wee1 inhibitors
AstraZeneca wins two recommendations, one priority review
Morningstar
Mon, 07/25/22 - 10:54 am
Tags:
AstraZeneca, Europe, Daiichi Sankyo, Enhertu, breast cancer, Ultomiris, Tezspire
Study shows AstraZeneca's Covid-19 mAb Evusheld may not work against dominant Omicron strain
Endpoints
Thu, 07/21/22 - 10:39 am
Tags:
AstraZeneca, COVID-19, Evusheld, Omicron variant
AstraZeneca, Pfizer, Novartis and more lose out in China's latest round of drug price cuts
Fierce Pharma
Wed, 07/13/22 - 10:03 am
Tags:
China, drug pricing, price cuts, AstraZeneca, Pfizer, Novartis, generics
AstraZeneca, GSK and more weathered Q2's economic headwinds, but Roche's stock took a hit: analysts
Fierce Pharma
Wed, 07/6/22 - 11:41 pm
Tags:
AstraZeneca, GSK, Roche
Biopharma Investment in China is Thriving Amid U.S. Downturn
BioSpace
Tue, 07/5/22 - 11:52 pm
Tags:
China, biotech, WuXi Biologics, Boehringer Ingelheim, Siemens Healthineers, AstraZeneca
AstraZeneca agrees $1.3bn deal to buy oncology player TeneoTwo
Pharmaforum
Tue, 07/5/22 - 11:57 am
Tags:
AstraZeneca, TeneoTwo, M&A, hematologic cancers
Oxford Biomedica signs up for 3 more years of making AstraZeneca COVID shots⁠—on an 'as needed basis'
Fierce Pharma
Fri, 07/1/22 - 10:29 am
Tags:
COVID-19, AstraZeneca, Oxford BioMedica, vaccines
AstraZeneca, chasing immunotherapy rivals, claims study success in early lung cancer
BioPharma Dive
Thu, 06/30/22 - 11:01 am
Tags:
AstraZeneca, Imfinzi, clinical trials, non-small cell lung cancer
Big pharma’s key third-quarter data
EP Vantage
Tue, 06/28/22 - 10:37 am
Tags:
GSK, Roche, Pfizer, JNJ, AstraZeneca, Novo Nordisk vaccines, clinical trials, pneumococcal disease, crovalimab, rheumatoid arthritis
Data backs AZ’s Wilson disease drug, but with a question mark
Pharmaforum
Fri, 06/24/22 - 10:26 am
Tags:
AstraZeneca, Wilson disease, Alexion, ALXN1840
PhaseBio’s Reversal Agent for Astra’s Brilinta could Spell Success for Both
BioSpace
Thu, 06/23/22 - 10:32 am
Tags:
PhaseBio, AstraZeneca, Brilinta, antiplatelet therapy
AstraZeneca continues to build out its presence in China with new COPD drug manufacturing site
Endpoints
Wed, 06/22/22 - 06:55 pm
Tags:
AstraZeneca, China, COPD, drug manufacturing
AZ preps FDA filing for $3.6bn amyloidosis drug eplontersen
Pharmaforum
Tue, 06/21/22 - 10:57 am
Tags:
AstraZeneca, eplontersen, Ionis, ATTR
Rumor mill says AstraZeneca may be eyeing a takeover of Mereo
Pharmaforum
Fri, 06/17/22 - 10:41 am
Tags:
AstraZeneca, Mereo BioPharma, M&A
This Cancer Drug's News Could Mean Another Blockbuster for AstraZeneca
Motley Fool
Tue, 06/14/22 - 11:42 am
Tags:
AstraZeneca, breast cancer, Enhertu
AstraZeneca trots out Evusheld data to expand the COVID preventive drug into the treatment arena
Fierce Pharma
Wed, 06/8/22 - 11:09 pm
Tags:
AstraZeneca, Evusheld, COVID-19
Pascal Soriot wouldn't 'do anything differently' in Covid-19 vaccine development — report
Endpoints
Tue, 06/7/22 - 10:09 am
Tags:
AstraZeneca, Pharma CEOs, Pascal Soriot, vaccines, COVID-19
ASCO22: Enhertu aces key HER2-low test in breast cancer
Pharmaforum
Mon, 06/6/22 - 09:43 am
Tags:
ASCO 2022, AstraZeneca, Daiichi Sankyo, Enhertu, HER2-low breast cancer, breast cancer
Knighthood for AstraZeneca's Pascal Soriot
Spectator Australia
Thu, 06/2/22 - 10:18 am
Tags:
AstraZeneca, Pascal Soriot, Pharma CEOs

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.